首页> 外文OA文献 >Pathogenic potential of anti-ganglioside antibodies in a murine model of axonal Guillain-Barré syndrome
【2h】

Pathogenic potential of anti-ganglioside antibodies in a murine model of axonal Guillain-Barré syndrome

机译:抗神经节苷脂抗体在轴突格林 - 巴利综合征小鼠模型中的致病潜力

摘要

Guillian-Barré Syndrome (GBS) is the world’s leading cause of neuromuscular paralysis occurring in serologically and pathogenically distinct forms. GBS is believed to have an autoimmune basis, where antibodies raised during antecedent infections (eg Campylobacter jejuni) cross-react with self antigens, exemplifying the process of molecular mimicry. These self-antigens are gangliosides, which are glycolipid structures enriched in peripheral nerve in specific membrane compartments termed lipid rafts. To date, successful murine models of anti-GD1a and anti-Gq1b ganglioside mediated neuropathy exist. Clinical evidence supports the involvement of anti-GM1 antibodies in nerve injury, however generation of anti-GM1 antibody mediated neuropathy models remain an enigma, and to date, the only successful model is based in Japanese rabbits. This thesis aims to address the controversies surrounding anti-GM1 antibody mediated neuropathy by utilising a panel of anti-GM1 antibodies of differing specificity, and explores how the stereometric interactions of GM1 with lipid raft species underpin the pathogenic potential of these antibodies.
机译:Guillian-Barré综合征(GBS)是世界上以血清学和病原学上不同的形式发生神经肌肉麻痹的主要原因。 GBS被认为具有自身免疫基础,在此之前感染期间产生的抗体(例如空肠弯曲杆菌)与自身抗原发生交叉反应,这是分子模拟过程的例证。这些自身抗原是神经节苷脂,其是在称为脂筏的特定膜区室中富集在周围神经中的糖脂结构。迄今为止,存在成功的抗GD1a和抗Gq1b神经节苷脂介导的神经病的鼠模型。临床证据支持抗GM1抗体参与神经损伤,但是抗GM1抗体介导的神经病变模型的产生仍然是一个谜,迄今为止,唯一成功的模型是基于日本兔的。本论文旨在通过利用一组不同特异性的抗GM1抗体解决围绕抗GM1抗体介导的神经病的争议,并探讨GM1与脂质筏物种的立体相互作用如何支撑这些抗体的致病性。

著录项

  • 作者

    Greenshields Kay;

  • 作者单位
  • 年度 2007
  • 总页数
  • 原文格式 PDF
  • 正文语种 English
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号